Implementation of an Online Drug–Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19 - Top-Institutions - MDSpire

Implementation of an Online Drug–Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19

  • By

  • Joshua P Havens

  • Nayon Kang

  • Lucy Chung

  • Courtney V Fletcher

  • Page Crew

  • Jacqueline Nordwall

  • Lianne Siegel

  • Katrina Harper

  • Birgit Grund

  • Marcelo Losso

  • Shikha Vasudeva

  • Kyle C Molina

  • Adit A Ginde

  • Ryosuke Shimizu

  • Ahmad Mourad

  • Alpha Diallo

  • Mina Pak

  • Anne Davis-Karim

  • Phiona Nabaggala

  • Alfredo J Mena Lora

  • Derek W Russell

  • Sho Saito

  • Jason V Baker

  • for the STRIVE Ensitrelvir Trial Study Group and the STRIVE Network

  • June 11, 2025

  • 0 min

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)
    National Institutes of Health (NIH) - National Institute of Allergy and Infectious Diseases (NIAID)

    Bethesda, MD

    Key Differentiators

    • Infectious Diseases
    • Clinical Pharmacology
    • Clinical Trial Research

  • #2

    University of California, San Francisco (UCSF) School of Medicine
    University of California, San Francisco (UCSF) School of Medicine

    San Francisco, CA

    Key Differentiators

    • Infectious Diseases
    • Clinical Pharmacology
    • Digital Health

  • #3

    Massachusetts General Hospital (MGH) - Harvard Medical School
    Massachusetts General Hospital (MGH) - Harvard Medical School

    Boston, MA

    Key Differentiators

    • Infectious Diseases
    • Clinical Pharmacology
    • Clinical Informatics

  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Infectious Diseases
    • Pharmacology
    • Clinical Trial Design

  • #5

    University of Washington School of Medicine
    University of Washington School of Medicine

    Seattle, WA

    Key Differentiators

    • Infectious Diseases
    • Clinical Pharmacology
    • Epidemiology

Original Source(s)

Implementation of an Online Drug–Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19

  • by Joshua P Havens, Nayon Kang, Lucy Chung, Courtney V Fletcher, Page Crew, Jacqueline Nordwall, Lianne Siegel, Katrina Harper, Birgit Grund, Marcelo Losso, Shikha Vasudeva, Kyle C Molina, Adit A Ginde, Ryosuke Shimizu, Ahmad Mourad, Alpha Diallo, Mina Pak, Anne Davis-Karim, Phiona Nabaggala, Alfredo J Mena Lora, Derek W Russell, Sho Saito, Jason V Baker, for the STRIVE Ensitrelvir Trial Study Group and the STRIVE Network

  • June 11, 2025

Related Content

Case Report: Successful treatment of recurrent COVID-19 with intravenous immunoglobulin in a patient with rituximab-induced B-cell depletion and restoration of Fc-mediated effector functions

The latest developments on Ebola, hepatitis B, long Covid

Permanent hypoparathyroidism following SARS-CoV-2 infection: a case report with two-year follow-up and literature review